# Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma

> **NCT01938729** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Intrahepatic Cholangiocarcinoma
- Peripheral Cholangiocarcinoma
- Cholangiolar Carcinoma
- Cholangiocellular Carcinoma) (ICC)

## Interventions

- **PROCEDURE:** Liver resection and placement of hepatic artery infusion pump
- **DRUG:** FLOXURIDINE
- **DRUG:** DEXAMETHASONE
- **DRUG:** GEMCITABINE

## Key facts

- **NCT ID:** NCT01938729
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-05
- **Primary completion:** 2020-09-10
- **Final completion:** 2020-09-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-09-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01938729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01938729, "Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01938729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*